<prompt> New indication of tolvaptan as approved by FDA recentlyPhenylketonuriaPancreatic tumoursPolycystic ovarian diseasePolycystic kidney disease  <response>: Tolvaptan is a vasopressin antagonist used for SIADH Now approved for PCKD Ref : HH Sharma 3rd ed. 